Transfection of an Inducible Gene Expression System into Cells Expressing a Bacterial Effector Protein
JoVE Encyclopedia of Experiments
Microbiology
0 views • 2:43 min • November 28th, 2025
Loading...
Overview
This study investigates the role of CaeB, an anti-apoptotic bacterial protein, in modulating apoptosis in human cells. By utilizing a tetracycline-inducible gene expression system, the effects of CaeB on pro-apoptotic signaling are examined.
Key Study Components
Area of Science
- Cell Biology
- Apoptosis
- Gene Expression
Background
- CaeB is known to inhibit apoptosis in various cellular contexts.
- Understanding the mechanisms of apoptosis is crucial for therapeutic interventions.
- Transfection techniques allow for the study of gene function in live cells.
- Tetracycline-inducible systems provide controlled expression of target genes.
Purpose of Study
- To determine the effect of CaeB on pro-apoptotic protein expression.
- To assess the role of CaeB in apoptotic signaling pathways.
- To utilize a controlled gene expression system for precise experimental outcomes.
Methods Used
- Human HEK293 cells expressing CaeB were used alongside control cells.
- A tetracycline-inducible gene expression system was employed.
- Cells were transfected with plasmids encoding pro-apoptotic proteins.
- Apoptotic signaling was assessed through marker activation.
Main Results
- CaeB-expressing cells showed reduced activation of apoptotic markers.
- Control cells exhibited typical apoptotic signaling upon induction.
- The presence of CaeB significantly inhibited pro-apoptotic signaling.
- Results suggest that CaeB plays a protective role against apoptosis.
Conclusions
- CaeB effectively inhibits apoptosis in human cells.
- This study highlights the potential of CaeB in therapeutic applications.
- Further research is needed to explore the mechanisms of CaeB action.
Frequently Asked Questions
What is CaeB?
CaeB is an anti-apoptotic bacterial protein that inhibits programmed cell death.
How does the tetracycline-inducible system work?
It allows controlled expression of genes in response to tetracycline or its analogs.
What cell line was used in this study?
HEK293 cells were used, both expressing CaeB and as control cells.
What was the main finding of the study?
CaeB inhibits apoptotic signaling, reducing activation of apoptotic markers.
What implications do these findings have?
They suggest potential therapeutic applications for CaeB in preventing apoptosis.
What methods were used to assess apoptosis?
Apoptotic signaling was assessed through the activation of specific markers.
Executive Industry Relevance
Inducible gene expression systems enable precise interrogation of host-pathogen interactions and mechanistic de-risking in early discovery. This approach allows biopharma teams to pinpoint where bacterial effectors, such as CaeB, disrupt critical signaling pathways like apoptosis. Such mechanistic clarity supports predictive confidence and informs target validation decisions across the discovery pipeline.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Enables functional dissection of effector protein impact on host signaling pathways.
- Supports mechanistic de-risking by isolating the point of pathway disruption.
- Facilitates robust target validation through controlled gene induction and quantitative readouts.
Screening & Assay Development
- Prepares validated cellular systems for downstream screening of modulators or inhibitors.
- Standardizes assay conditions using inducible expression for reproducible outputs.
- Enables quantitative measurement of pathway activity via apoptotic marker activation.
Translational & Preclinical Research
- Aligns mechanistic findings with disease-relevant pathways for translational continuity.
- Supports risk-adjusted advancement by clarifying effector impact on cell fate decisions.
- Provides a platform for evaluating candidate interventions in a controlled genetic context.
Pipeline & Workflow Integration
This inducible system integrates at the interface of early discovery and lead identification, supporting hypothesis-driven pathway interrogation and assay readiness for screening campaigns.
- Discovery Biology: Enables null hypothesis testing to clarify effector protein mechanisms in host cells.
- Screening: Delivers reproducible, quantitative apoptotic marker data for comparative analysis.
- Analytics: Provides clear statistical outputs to distinguish pathway modulation by effectors.
- Translational Research: Bridges mechanistic insights to preclinical model selection when pathway relevance is established.
- Enterprise Reuse: Offers a modular, inducible platform adaptable to diverse effector-target studies.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence in target-pathway relationships and reduces mechanistic ambiguity.
- Operational Value: Standardizes experimental conditions for reproducibility and scalability across teams.
- Strategic Value: Informs go/no-go decisions by clarifying biological risk early in the pipeline.
- Portfolio Impact: Supports risk-adjusted prioritization of targets and mechanisms for advancement.
Implementation Considerations
- Requires expertise in mammalian cell culture and transfection techniques.
- Needs access to inducible gene expression vectors and compatible analytical assays.
- Demands cross-team standardization of induction protocols and marker quantification.
- May require adaptation for different cell lines or effector proteins.
- Dependent on robust statistical analysis to interpret quantitative marker data.
Biopharma FAQs
Why does null hypothesis testing of CaeB-mediated apoptosis matter for target validation?
Null hypothesis testing using inducible pro-apoptotic gene expression clarifies whether CaeB directly disrupts apoptotic signaling, supporting functional target validation and reducing mechanistic uncertainty in early discovery.
How does independent variable isolation via tetracycline induction fit the discovery pipeline?
Tetracycline-controlled induction isolates the effect of pro-apoptotic gene expression, enabling precise attribution of pathway changes to CaeB and supporting robust mechanistic de-risking in the discovery workflow.
What do quantitative apoptotic marker measurements enable in this workflow?
Quantitative measurement of apoptotic markers provides objective data to compare pathway activity between CaeB-expressing and control cells, informing data-driven decisions on effector impact and target prioritization.
Why are replication requirements critical for cross-functional collaboration in this assay?
Replication ensures that observed differences in apoptotic marker activation are robust and reproducible, facilitating reliable data sharing and interpretation across discovery, screening, and translational teams.
What statistical analysis capabilities are required before implementing this inducible system?
Teams must apply statistical methods to compare marker activation between experimental groups, ensuring that observed effects of CaeB are significant and actionable for downstream R&D decisions.
10:29
Applying Fluorescence Resonance Energy Transfer (FRET) to Examine Effector Translocation Efficiency by Coxiella burnetii during siRNA Silencing
Related Videos
0 Views
11:19
Inducing a Site Specific Replication Blockage in E. coli Using a Fluorescent Repressor Operator System
Related Videos
0 Views
07:10
A Fluorescence-based Method to Study Bacterial Gene Regulation in Infected Tissues
Related Videos
0 Views
02:57
Inducible Expression of Histidine-Tagged Ricin Toxin A Chain in E. coli
Related Videos
0 Views
06:19
Inducible Tet-Off Regulatable System: An In Vitro Method to Modulate Gene Expression in Cultured Cells Using Tetracycline-Off System
Related Videos
0 Views
04:41
Introduction of Bacterial Effector Proteins into Mammalian Cells by Electroporation
Related Videos
0 Views
08:39
Electroporation of Functional Bacterial Effectors into Mammalian Cells
Related Videos
0 Views
08:51
Applying an Inducible Expression System to Study Interference of Bacterial Virulence Factors with Intracellular Signaling
Related Videos
0 Views
10:00
Controllable Ion Channel Expression through Inducible Transient Transfection
Related Videos
0 Views
12:09
Transient Expression and Cellular Localization of Recombinant Proteins in Cultured Insect Cells
Related Videos
0 Views
Last updated: 22 August 2026